nach oben

Erschienen in:

23.07.2021 | Original Article

Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study

verfasst von: Domenico Corica, Antonio Bottari, Tommaso Aversa, Letteria Anna Morabito, Selenia Curatola, Angela Alibrandi, Giorgio Ascenti, Malgorzata Wasniewska

Erschienen in: Endocrine | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The increased incidence of childhood obesity and related non-alcoholic fatty liver disease (NAFLD) has determined the need to identify a non-invasive technique to diagnose and monitor NAFLD. Two-dimensional shear wave elastography (2D-SWE) has emerged as a reliable, non-invasive, tool to evaluate liver tissue elasticity in clinical practice. Aims of this study were to longitudinally evaluate 2D-SWE changes in relation to weight loss, metabolic profile, and body composition modifications and to investigate the correlation between 2D-SWE variation and clinical and biochemical indices of cardio-metabolic risk in obese children.

Methods

Thirty-three children underwent anthropometric, bioimpedenziometric, fasting biochemical assessments, ultrasound, and SWE evaluations, at baseline (V0) and after a 12-months of follow-up (V12). Diet and physical activity programs have been prescribed to all patients according to European Society of Endocrinology and Pediatric Endocrine Society recommendations. Adherence to the prescribed diet and physical activity program was checked every 3 months during the 12-month of follow-up. Variation of all parameters was evaluated in intragroup and intergroup comparison analysis in children, who had not lost weight (Group A) and those who had lost weight (Group B) at V12. Study population was also analyzed dividing it into two groups with respect to 2D-SWE liver elasticity value ≤10.6 kPa or >10.6 kPa.

Results

A significant reduction of mean 2D-SWE value was demonstrated both in the entire cohort (p = 0.002) and in Group B children (p = 0.004). Intragroup comparison analysis, between V0 and V12, documented a significant decrease of 2D-SWE and BMI SDS and a significant improvement of metabolic profile (decrease of HOMA-IR, HbA1c, oral glucose tolerance test 120-min glucose and insulin, triglycerides, triglycerides/HDL-ratio, transaminases, uric acid, and increase of Matsuda-index and HDL) in children of Group B but not in those of Group A. Intergroup comparison analysis showed significant differences for BMI, BMI SDS, transaminases and several parameters of glucose and lipid metabolism, between Group A and Group B children after 12-months of follow-up. No significant differences were documented with regard to clinical and biochemical variables by dividing the population in accordance with the 2D-SWE cut-off of 10.6 kPa.

Conclusions

These results suggested a relation between weight loss, metabolic profile improvement and 2D-SWE value reduction. SWE could play a significant role in the non-invasive assessment of NAFLD in children and adolescents with obesity.

Nur mit Berechtigung zugänglich

A. Engeland, T. Bjorge, A. Tverdal, A.J. Sogaard, Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 15(1), 79–85 (2004). https://doi.org/10.1097/01.ede.0000100148.40711.59CrossRefPubMed

P.W. Franks, R.L. Hanson, W.C. Knowler, M.L. Sievers, P.H. Bennett, H.C. Looker, Childhood obesity, other cardiovascular risk factors, and premature death. N. Engl. J. Med. 362(6), 485–493 (2010). https://doi.org/10.1056/NEJMoa0904130CrossRefPubMedPubMedCentral

K. Tominaga, J.H. Kurata, Y.K. Chen, E. Fujimoto, S. Miyagawa, I. Abe, Y. Kusano, Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig. Dis. Sci. 40(9), 2002–2009 (1995). https://doi.org/10.1007/BF02208670CrossRefPubMed

J.B. Schwimmer, R. Deutsch, T. Kahen, J.E. Lavine, C. Stanley, C. Behling, Prevalence of fatty liver in children and adolescents. Pediatrics 118(4), 1388–1393 (2006). https://doi.org/10.1542/peds.2006-1212CrossRefPubMed

A. Sartorio, A. Del Col, F. Agosti, G. Mazzilli, S. Bellentani, C. Tiribelli, G. Bedogni, Predictors of non-alcoholic fatty liver disease in obese children. Eur. J. Clin. Nutr. 61(7), 877–883 (2007). https://doi.org/10.1038/sj.ejcn.1602588CrossRefPubMed

A.A. Mencin, J.E. Lavine, Nonalcoholic fatty liver disease in children. Curr. Opin. Clin. Nutr. Metab. Care 14(2), 151–157 (2011). https://doi.org/10.1097/MCO.0b013e328342baecCrossRefPubMed

M. Eslam, A.J. Sanyal, J. George; International Consensus, P., MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7), 1999–2014 (2020). https://doi.org/10.1053/j.gastro.2019.11.312. e1991CrossRefPubMed

S. Berardis, E. Sokal, Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur. J. Pediatr. 173(2), 131–139 (2014). https://doi.org/10.1007/s00431-013-2157-6CrossRefPubMed

S.A. AlKhater, Paediatric non-alcoholic fatty liver disease: an overview. Obes. Rev. 16(5), 393–405 (2015). https://doi.org/10.1111/obr.12271CrossRefPubMed

10.

P. Vajro, S. Lenta, P. Socha, A. Dhawan, P. McKiernan, U. Baumann, O. Durmaz, F. Lacaille, V. McLin, V. Nobili, Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J. Pediatr. Gastroenterol. Nutr. 54(5), 700–713 (2012). https://doi.org/10.1097/MPG.0b013e318252a13fCrossRefPubMed

11.

A. Dezsofi, U. Baumann, A. Dhawan, O. Durmaz, B. Fischler, N. Hadzic, L. Hierro, F. Lacaille, V.A. McLin, V. Nobili, P. Socha, P. Vajro, A.S. Knisely, E.H. Committee, Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J. Pediatr. Gastroenterol. Nutr. 60(3), 408–420 (2015). https://doi.org/10.1097/MPG.0000000000000632CrossRefPubMed

12.

I. Doycheva, J. Cui, P. Nguyen, E.A. Costa, J. Hooker, H. Hofflich, R. Bettencourt, S. Brouha, C.B. Sirlin, R. Loomba, Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol. Ther. 43(1), 83–95 (2016). https://doi.org/10.1111/apt.13405CrossRefPubMed

13.

P. Angulo, D.E. Kleiner, S. Dam-Larsen, L.A. Adams, E.S. Bjornsson, P. Charatcharoenwitthaya, P.R. Mills, J.C. Keach, H.D. Lafferty, A. Stahler, S. Haflidadottir, F. Bendtsen, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients With nonalcoholic fatty liver disease. Gastroenterology 149(2), 389–397 (2015). https://doi.org/10.1053/j.gastro.2015.04.043CrossRefPubMed

14.

M. Ekstedt, H. Hagstrom, P. Nasr, M. Fredrikson, P. Stal, S. Kechagias, R. Hultcrantz, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61(5), 1547–1554 (2015). https://doi.org/10.1002/hep.27368CrossRefPubMed

15.

M.J. Noruegas, H. Matos, I. Goncalves, M.A. Cipriano, C. Sanches, Acoustic radiation force impulse-imaging in the assessment of liver fibrosis in children. Pediatr. Radiol. 42(2), 201–204 (2012). https://doi.org/10.1007/s00247-011-2257-2CrossRefPubMed

16.

S. Hanquinet, D. Courvoisier, A. Kanavaki, A. Dhouib, M. Anooshiravani, Acoustic radiation force impulse imaging-normal values of liver stiffness in healthy children. Pediatr. Radiol. 43(5), 539–544 (2013). https://doi.org/10.1007/s00247-012-2553-5CrossRefPubMed

17.

G. Ferraioli, P. Parekh, A.B. Levitov, C. Filice, Shear wave elastography for evaluation of liver fibrosis. J. Ultrasound Med. 33(2), 197–203 (2014). https://doi.org/10.7863/ultra.33.2.197CrossRefPubMed

18.

J.R. Dillman, A. Heider, J.L. Bilhartz, E.A. Smith, N. Keshavarzi, J.M. Rubin, M.J. Lopez, Ultrasound shear wave speed measurements correlate with liver fibrosis in children. Pediatr. Radiol. 45(10), 1480–1488 (2015). https://doi.org/10.1007/s00247-015-3345-5CrossRefPubMedPubMedCentral

19.

M. Garcovich, S. Veraldi, E. Di Stasio, M.A. Zocco, L. Monti, P. Toma, M. Pompili, A. Gasbarrini, V. Nobili, Liver stiffness in pediatric patients with fatty liver disease: diagnostic accuracy and reproducibility of shear-wave elastography. Radiology 283(3), 820–827 (2017). https://doi.org/10.1148/radiol.2016161002CrossRefPubMed

20.

S. Ciardullo, T. Monti, G. Perseghin, Prevalence of liver steatosis and fibrosis detected by transient elastography in adolescents in the 2017–2018 National Health and Nutrition Examination Survey. Clin. Gastroenterol. Hepatol. 19(2), 384–390 (2021). https://doi.org/10.1016/j.cgh.2020.06.048CrossRefPubMed

21.

V. Nobili, F. Vizzutti, U. Arena, J.G. Abraldes, F. Marra, A. Pietrobattista, R. Fruhwirth, M. Marcellini, M. Pinzani, Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48(2), 442–448 (2008). https://doi.org/10.1002/hep.22376CrossRefPubMed

22.

C.F. Dietrich, J. Bamber, A. Berzigotti, S. Bota, V. Cantisani, L. Castera, D. Cosgrove, G. Ferraioli, M. Friedrich-Rust, O.H. Gilja, R.S. Goertz, T. Karlas, R. de Knegt, V. de Ledinghen, F. Piscaglia, B. Procopet, A. Saftoiu, P.S. Sidhu, I. Sporea, M. Thiele, EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Long Version). Ultraschall Med. 38(4), e16–e47 (2017). https://doi.org/10.1055/s-0043-103952CrossRefPubMed

23.

R.G. Barr, G. Ferraioli, M.L. Palmeri, Z.D. Goodman, G. Garcia-Tsao, J. Rubin, B. Garra, R.P. Myers, S.R. Wilson, D. Rubens, D. Levine, Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276(3), 845–861 (2015). https://doi.org/10.1148/radiol.2015150619CrossRefPubMed

24.

N.K. Desai, S. Harney, R. Raza, A. Al-Ibraheemi, N. Shillingford, P.D. Mitchell, M.M. Jonas, Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J. Pediatr. 173, 160–164 (2016). https://doi.org/10.1016/j.jpeds.2016.03.021CrossRefPubMedPubMedCentral

25.

M. de Onis, A.W. Onyango, E. Borghi, A. Siyam, C. Nishida, J. Siekmann, Development of a WHO growth reference for school-aged children and adolescents. Bull. World Health Organ. 85(9), 660–667 (2007). https://doi.org/10.2471/blt.07.043497CrossRefPubMedPubMedCentral

26.

D.M. Styne, S.A. Arslanian, E.L. Connor, I.S. Farooqi, M.H. Murad, J.H. Silverstein, J.A. Yanovski, Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102(3), 709–757 (2017). https://doi.org/10.1210/jc.2016-2573CrossRefPubMedPubMedCentral

27.

D. Corica, L. Oreto, G. Pepe, M.P. Calabro, L. Longobardo, L. Morabito, G.B. Pajno, A. Alibrandi, T. Aversa, M. Wasniewska, Precocious preclinical cardiovascular sonographic markers in metabolically healthy and unhealthy childhood obesity. Front. Endocrinol. 11, 56 (2020). https://doi.org/10.3389/fendo.2020.00056CrossRef

28.

D. Corica, C. Zusi, F. Olivieri, M. Marigliano, C. Piona, E. Fornari, A. Morandi, M. Corradi, E. Miraglia Del Giudice, D. Gatti, M. Rossini, R.C. Bonadonna, C. Maffeis, Vitamin D affects insulin sensitivity and beta-cell function in obese non-diabetic youths. Eur. J. Endocrinol. 181(4), 439–450 (2019). https://doi.org/10.1530/EJE-19-0369CrossRefPubMed

29.

B. Wang, M. Li, Z. Zhao, S. Wang, J. Lu, Y. Chen, M. Xu, W. Wang, G. Ning, Y. Bi, T. Wang, Y. Xu, Glycemic measures and development and resolution of nonalcoholic fatty liver disease in nondiabetic individuals. J. Clin. Endocrinol. Metab. 105(5), 1416–1426 (2020). https://doi.org/10.1210/clinem/dgaa112CrossRef

30.

S.H. Kim, J.M. Lee, J.H. Kim, K.G. Kim, J.K. Han, K.H. Lee, S.H. Park, N.J. Yi, K.S. Suh, S.K. An, Y.J. Kim, K.R. Son, H.S. Lee, B.I. Choi, Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images–initial experience. Radiology 234(3), 793–803 (2005). https://doi.org/10.1148/radiol.2343040142CrossRefPubMed

31.

A.B. Mjelle, A. Mulabecirovic, R.F. Havre, K. Rosendahl, P.B. Juliusson, E. Olafsdottir, O.H. Gilja, M. Vesterhus, Normal liver stiffness values in children: a comparison of three different elastography methods. J. Pediatr. Gastroenterol. Nutr. 68(5), 706–712 (2019). https://doi.org/10.1097/MPG.0000000000002320CrossRefPubMedPubMedCentral

32.

A.B. Mjelle, A. Mulabecirovic, R.F. Havre, E.J. Olafsdottir, O.H. Gilja, M. Vesterhus, Liver elastography in healthy children using three different systems—how many measurements are necessary? Ultraschall. Med. (2020). https://doi.org/10.1055/a-1283-5906

33.

O. Tutar, O.F. Beser, I. Adaletli, N. Tunc, D. Gulcu, F. Kantarci, I. Mihmanli, F.C. Cokugras, T. Kutlu, G. Ozbay, T. Erkan, Shear wave elastography in the evaluation of liver fibrosis in children. J Pediatr Gastroenterol. Nutr. 58(6), 750–755 (2014). https://doi.org/10.1097/MPG.0000000000000329CrossRefPubMed

34.

G.T. Brown, D.E. Kleiner, Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 65(8), 1080–1086 (2016). https://doi.org/10.1016/j.metabol.2015.11.008CrossRefPubMed

35.

B.H. Park, J.M. Yoon, J.H. Kim, J.H. Moon, Y.H. Lee, S.M. Jang, Y.J. Kim, Pathologic impact of insulin resistance and sensitivity on the severity of liver histopathology in pediatric non-alcoholic steatohepatitis. Yonsei Med. J. 58(4), 756–762 (2017). https://doi.org/10.3349/ymj.2017.58.4.756CrossRefPubMedPubMedCentral

36.

M. Arata, J. Nakajima, S. Nishimata, T. Nagata, H. Kawashima, Nonalcoholic steatohepatitis and insulin resistance in children. World J. Diabetes 5(6), 917–923 (2014). https://doi.org/10.4239/wjd.v5.i6.917CrossRefPubMedPubMedCentral

37.

P. Di Bonito, G. Valerio, M.R. Licenziati, E. Miraglia Del Giudice, M.G. Baroni, A. Morandi, C. Maffeis, G. Campana, M.R. Spreghini, A. Di Sessa, G. Morino, A. Crino, C. Chiesa, L. Pacifico, M. Manco, High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. J. Endocrinol. Invest. 43(4), 461–468 (2020). https://doi.org/10.1007/s40618-019-01130-6CrossRefPubMed

38.

J. Yang, L. Lin, E. Xue, D. Hong, Y. Yang, M. Xu, Z. Chen, Can Nonfibrotic nonalcoholic steatohepatitis be effectively identified by supersonic shear imaging? Anal. Cell Pathol. 2019, 2013674 (2019). https://doi.org/10.1155/2019/2013674CrossRef

39.

J. Chen, J.A. Talwalkar, M. Yin, K.J. Glaser, S.O. Sanderson, R.L. Ehman, Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259(3), 749–756 (2011). https://doi.org/10.1148/radiol.11101942CrossRefPubMedPubMedCentral

40.

P.C. Georges, J.J. Hui, Z. Gombos, M.E. McCormick, A.Y. Wang, M. Uemura, R. Mick, P.A. Janmey, E.E. Furth, R.G. Wells, Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293(6), G1147–G1154 (2007). https://doi.org/10.1152/ajpgi.00032.2007CrossRefPubMed

41.

N. Salameh, B. Larrat, J. Abarca-Quinones, S. Pallu, M. Dorvillius, I. Leclercq, M. Fink, R. Sinkus, B.E. Van Beers, Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 253(1), 90–97 (2009). https://doi.org/10.1148/radiol.2523081817CrossRefPubMed

42.

C.O. Marginean, C. Marginean, Elastographic assessment of liver fibrosis in children: a prospective single center experience. Eur. J. Radiol. 81(8), e870–e874 (2012). https://doi.org/10.1016/j.ejrad.2012.04.014CrossRefPubMed

43.

C. Cassinotto, J. Boursier, V. de Ledinghen, J. Lebigot, B. Lapuyade, P. Cales, J.B. Hiriart, S. Michalak, B.L. Bail, V. Cartier, A. Mouries, F. Oberti, I. Fouchard-Hubert, J. Vergniol, C. Aube, Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63(6), 1817–1827 (2016). https://doi.org/10.1002/hep.28394CrossRefPubMed

44.

F. Guzman-Aroca, M.D. Frutos-Bernal, A. Bas, J.A. Lujan-Mompean, M. Reus, D. Berna-Serna Jde, P. Parrilla, Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur. Radiol. 22(11), 2525–2532 (2012). https://doi.org/10.1007/s00330-012-2505-3CrossRefPubMed

45.

V.W. Wong, J. Vergniol, G.L. Wong, J. Foucher, H.L. Chan, B. Le Bail, P.C. Choi, M. Kowo, A.W. Chan, W. Merrouche, J.J. Sung, V. de Ledinghen, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51(2), 454–462 (2010). https://doi.org/10.1002/hep.23312CrossRefPubMed

46.

M. Yoneda, K. Suzuki, S. Kato, K. Fujita, Y. Nozaki, K. Hosono, S. Saito, A. Nakajima, Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256(2), 640–647 (2010). https://doi.org/10.1148/radiol.10091662CrossRefPubMed

47.

D.W. Kim, C. Park, H.M. Yoon, A.Y. Jung, J.S. Lee, S.C. Jung, Y.A. Cho, Technical performance of shear wave elastography for measuring liver stiffness in pediatric and adolescent patients: a systematic review and meta-analysis. Eur. Radiol. 29(5), 2560–2572 (2019). https://doi.org/10.1007/s00330-018-5900-6CrossRefPubMed

48.

U. Arena, F. Vizzutti, G. Corti, S. Ambu, C. Stasi, S. Bresci, S. Moscarella, V. Boddi, A. Petrarca, G. Laffi, F. Marra, M. Pinzani, Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47(2), 380–384 (2008). https://doi.org/10.1002/hep.22007CrossRefPubMed

49.

M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, G. Ronchi, D. Conte, M. Rumi, P. Lampertico, M. Colombo, Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J. Hepatol. 54(4), 621–628 (2011). https://doi.org/10.1016/j.jhep.2010.07.017CrossRefPubMed

50.

K. Sugimoto, F. Moriyasu, H. Oshiro, H. Takeuchi, M. Abe, Y. Yoshimasu, Y. Kasai, K. Sakamaki, T. Hara, T. Itoi, The role of Multiparametric US of the liver for the evaluation of nonalcoholic Steatohepatitis. Radiology 296(3), 532–540 (2020). https://doi.org/10.1148/radiol.2020192665CrossRefPubMed

Titel: Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study
verfasst von: Domenico Corica
Antonio Bottari
Tommaso Aversa
Letteria Anna Morabito
Selenia Curatola
Angela Alibrandi
Giorgio Ascenti
Malgorzata Wasniewska
Publikationsdatum: 23.07.2021
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-021-02828-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules

French-Canadian families from Saguenay-Lac-Saint-Jean: a new founder population for APECED

Letter to the editor on the article of ‘Effects of dutasteride on sex hormones and cerebrospinal steroids in patients treated for benign prostatic hyperplasia’

The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21

Correction to: Incidence and predictive factors of postoperative hypocalcaemia according to type of thyroid surgery in older adults

Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin